Journal info


6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

2022

Late effects of childhood cancer recorded at a single outpatient clinic over the course of one year: implications for the follow-up care
Authors: Tomas KEPAK, Hana HRSTKOVA, Viera BAJCIOVA, Vitezslav DUSEK, Marta HOLIKOVA, Lucie STRUBLOVA, Katerina KEPAKOVA
Neoplasma Vol.69, No.4, p.983–992, 2022
doi:10.4149/neo_2022_220531N584
[View Abstract]


Clinical outcomes of EGFR-TKIs in advanced squamous cell lung cancer
Authors: Jin-Fei Si, Jing Xiang, Jing-Wen Wei, Yue Hao, Zheng-Bo Song
Neoplasma Vol.69, No.4, p.976–982, 2022
doi:10.4149/neo_2022_220329N348
[View Abstract]


NPM1 is a diagnostic and prognostic biomarker associated with the clinicopathological characteristics of gastric cancer
Authors: Chang-An Guo, Xiao-Lu Su, Wen-Jie Wang, Tian-Hong Xia, Xiao-Meng Cao, Shao-Bin Yuan, Wen-An Wang, An Zhang, Hong-Bin Liu
Neoplasma Vol.69, No.4, p.965–975, 2022
doi:10.4149/neo_2022_220303N237
[View Abstract]


High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements: Biopsy analysis of 70 cases from the Slovak Lymphoma Registry
Authors: Katarína Lešková, Peter Szépe, Tomáš Balhárek, Martina Barthová, Ľuboslava Janáková, Anna Farkašová, Lukáš Plank
Neoplasma Vol.69, No.4, p.957–964, 2022
doi:10.4149/neo_2022_220318N300
[View Abstract]


Impact of FDG PET/CT on detection of synchronous and metachronous malignancies and clinical management in patients with multiple primary cancers
Authors: Mihaela Ilcheva, Petya Nikolova, Valeria Hadzhiyska, Kiril Mladenov
Neoplasma Vol.69, No.4, p.948–956, 2022
doi:10.4149/neo_2022_220203N135
[View Abstract]


Silencing of B7-H4 induces intracellular oxidative stress and inhibits cell viability of breast cancer cells via downregulating PRDX3
Authors: Hao-Chuan Chen, Min Long, Zhao-Wei Gao, Chong Liu, Xia-Nan Wu, Lan Yang, Ke Dong, Hui-Zhong Zhang
Neoplasma Vol.69, No.4, p.940–947, 2022
doi:10.4149/neo_2022_220304N241
[View Abstract]


RETRACTION: miR-497 inhibits tumor growth and migration of osteosarcoma by targeting plexinA4 and CDK6
Authors: Z. S. TIAN, M. J. YAN, S. LI, D. CONG, Y. Y. WANG, Q. S. ZHU
Neoplasma Vol.69, No.4, p.993, 2022
doi:10.4149/neo_2022_200108N26R
Price: free access
[View Abstract]


Abnormal expression and clinical significance of surface receptors on natural killer cells in the peripheral blood of patients with non-small cell lung cancer
Authors: Peng-Cheng Liu, Xiao-Wen Feng, Xiao-Min Zhao, Jing Ye, Feng-Lian He, Hui Liu, Ren-Ming Li, Xue-Fu Wang, Da-Hai Zhao
Neoplasma Vol.69, No.4, p.931–939, 2022
doi:10.4149/neo_2022_220219N188
[View Abstract]


LncRNA CRNDE is involved in radiation resistance in hepatocellular carcinoma via modulating the SP1/PDK1 axis
Authors: Kai-Yun Chen, Shu-Guang Zhu, Ji-Wen He, Xiao-Peng Duan
Neoplasma Vol.69, No.4, p.918–930, 2022
doi:10.4149/neo_2022_211230N1853
[View Abstract]


SIRT5 promotes non-small cell lung cancer progression by reducing FABP4 acetylation level
Authors: Zhen Li, Dong-Ping Yu, Ning Wang, Ting Tao, Wu Luo, Hui Chen
Neoplasma Vol.69, No.4, p.909–917, 2022
doi:10.4149/neo_2022_220107N28
[View Abstract]


N-type calcium channel v2.2 is a target of TCF21 in adrenocortical carcinomas
Authors: Barbara dos Santos Passaia, Jean Lucas Kremer, Maria Candida Villares Fragoso, Claudimara Ferini Pacicco Lotfi
Neoplasma Vol.69, No.4, p.899–908, 2022
doi:10.4149/neo_2022_220106N25
[View Abstract]


The association of immune cell infiltration and prognostic value of tertiary lymphoid structures in gastric cancer
Authors: Ji-Shang Yu, Wei-Bin Huang, Yu-Hui Zhang, Jian Chen, Jin Li, Hua-Feng Fu, Zhe-Wei Wei, Yu-Long He
Neoplasma Vol.69, No.4, p.886–898, 2022
doi:10.4149/neo_2022_220128N123
[View Abstract]


Optimization of endometrial cancer organoids establishment by cancer-associated fibroblasts
Authors: Yu-Liang Wu, Jia-Qing Li, Zubaidan Sulaiman, Qi Liu, Chun-Yan Wang, Shu-Peng Liu, Zheng-Liang Gao, Zhong-Ping Cheng
Neoplasma Vol.69, No.4, p.877–885, 2022
doi:10.4149/neo_2022_211110N1597
[View Abstract]


Cystathionine β-synthase expression correlates with tumor development and poor prognosis in lung squamous cell carcinoma patients
Authors: Ya-Qing Han, Zi-Bo Zhang, Kun Wang, Guang-Jie Liu, Shao-Nan Xie, Qing-Yi Liu, Fang Liu
Neoplasma Vol.69, No.4, p.868–876, 2022
doi:10.4149/neo_2022_211207N1745
[View Abstract]


TM4SF1 promotes glioma malignancy through multiple mechanisms
Authors: Yan-Wen Zheng, Man Wang, Zhao-Min Zhong, Guo-Qing Wu, Ting Zhang, Li-Li Chen, Ming Li
Neoplasma Vol.69, No.4, p.859–867, 2022
doi:10.4149/neo_2022_211009N1427
[View Abstract]


The ETS1-LINC00278 negative feedback loop plays a role in COL4A1/COL4A2 regulation in laryngeal squamous cell carcinoma
Authors: Chuan Yang, Huan Cao, Jian-Wang Yang, Jian-Tao Wang, Miao-Miao Yu, Bao-Shan Wang
Neoplasma Vol.69, No.4, p.841–858, 2022
doi:10.4149/neo_2022_220310N263
[View Abstract]


LIMD2 promotes tumor proliferation, invasion, and epithelial-mesenchymal transition in clear cell renal cell carcinoma
Authors: Qi-Yu Zhong, Ying-Wei Xie, Zhi-Liang Chen, Yu-Qing Chen, Yue-Xin Liu, Wen-Lian Xie, Wei Yan
Neoplasma Vol.69, No.4, p.832–840, 2022
doi:10.4149/neo_2022_211130N1701
[View Abstract]


The oncogenic miR-27a/BTG2 axis promotes obesity-associated hepatocellular carcinoma by mediating mitochondrial dysfunction
Authors: Qi Su, Zi-Xin Xu, Min-Li Xiong, Hui-Yi Li, Ming-Yi Xu, Sheng-Zheng Luo
Neoplasma Vol.69, No.4, p.820–831, 2022
doi:10.4149/neo_2022_211227N1837
[View Abstract]


Anlotinib suppresses proliferation, migration, and immune escape of gastric cancer cells by activating the cGAS-STING/IFN-β pathway
Authors: Min Yuan, Xian-Ling Guo, Jian-Hua Chen, Yang He, Zhu-Qing Liu, He-Ping Zhang, Jie Ren, Qing Xu
Neoplasma Vol.69, No.4, p.807–819, 2022
doi:10.4149/neo_2022_211012N1441
[View Abstract]


Methylation-mediated expression of SPARC is correlated with tumor progression and poor prognosis of breast cancer
Authors: Xiao-Long Li, Jia-Li Li, Dong-Jie Qiu, Li Ma
Neoplasma Vol.69, No.4, p.794–806, 2022
doi:10.4149/neo_2022_211002N1401
[View Abstract]





Display #  
Results 1 - 20 of 97

© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.